Literature DB >> 20501858

Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ.

Vera Novitskaya1, Hanna Romanska, Marwa Dawoud, J Louise Jones, Fedor Berditchevski.   

Abstract

Tetraspanin CD151 is associated with laminin-binding integrins (i.e., alpha(3)beta(1), alpha(6)beta(1), and alpha(6)beta(4)) and regulates tumor cell migration and invasion. Here, we examined the role of CD151 in proliferation of mammary epithelial cells using in vitro and in vivo models. Depletion of CD151 suppressed growth of HB2 cells, a nontumorigenic breast epithelial cell line, in three-dimensional (3D) extracellular matrices (ECM) and in Matrigel-based xenografts. Whereas the presence of alpha(3)beta(1) (but not alpha(6) integrins) was necessary to support growth of HB2 cells in 3D ECM, the pro-proliferative activity of CD151 did not require direct interaction with integrins. Furthermore, depletion of CD151 potentiated formation of the internal lumen and partial restoration of polarity when HB2 cells were cultured in 3D ECM. This correlated with a decrease in phosphorylation levels of extracellular signal-regulated kinase 1/2 and cAkt in CD151-negative cells and increase in activation of caspase-3. Accordingly, the number of CD151-positive colonies with internal lumen was increased by approximately 5-fold when cells were cultured in the presence of MAP/ERK kinase (U0126) and phosphoinositide 3-kinase (LY29004) inhibitors. To establish the physiologic relevance of pro-proliferative and morphogenetic activities of CD151, we analyzed the expression of this tetraspanin in ductal carcinoma in situ (DCIS), which is characterized by neoplastic proliferation of mammary epithelial cells. Strong homogeneous membrane expression of CD151 was found to be associated with a high grade of DCIS (P = 0.004). Taken together, these results strongly suggest that CD151 complexes play a crucial role in the development of hyperproliferative diseases in the mammary gland. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501858      PMCID: PMC2883732          DOI: 10.1158/0008-5472.CAN-09-4330

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  The tetraspanin CD151 regulates cell morphology and intracellular signaling on laminin-511.

Authors:  Masashi Yamada; Yasuhiro Sumida; Akemi Fujibayashi; Kiyomitsu Fukaguchi; Noriko Sanzen; Ryoko Nishiuchi; Kiyotoshi Sekiguchi
Journal:  FEBS J       Date:  2008-05-19       Impact factor: 5.542

2.  Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro.

Authors:  Yoshito Takeda; Alexander R Kazarov; Catherine E Butterfield; Benjamin D Hopkins; Laura E Benjamin; Arja Kaipainen; Martin E Hemler
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

3.  Regulation of in situ to invasive breast carcinoma transition.

Authors:  Min Hu; Jun Yao; Danielle K Carroll; Stanislawa Weremowicz; Haiyan Chen; Daniel Carrasco; Andrea Richardson; Shelia Violette; Tatiana Nikolskaya; Yuri Nikolsky; Erica L Bauerlein; William C Hahn; Rebecca S Gelman; Craig Allred; Mina J Bissell; Stuart Schnitt; Kornelia Polyak
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

4.  CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization.

Authors:  Xiuwei H Yang; Andrea L Richardson; Maria I Torres-Arzayus; Pengcheng Zhou; Chandan Sharma; Alexander R Kazarov; Milena M Andzelm; Jack L Strominger; Myles Brown; Martin E Hemler
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

Review 5.  The roles of MAPKs in disease.

Authors:  Michael C Lawrence; Arif Jivan; Chunli Shao; Lingling Duan; Daryl Goad; Elma Zaganjor; Jihan Osborne; Kathleen McGlynn; Steve Stippec; Svetlana Earnest; Wei Chen; Melanie H Cobb
Journal:  Cell Res       Date:  2008-04       Impact factor: 25.617

6.  The role of the tetraspanin CD151 in primary keratinocyte and fibroblast functions: implications for wound healing.

Authors:  Sean M Geary; Allison J Cowin; Ben Copeland; Rosa M Baleato; Kaoru Miyazaki; Leonie K Ashman
Journal:  Exp Cell Res       Date:  2008-05-03       Impact factor: 3.905

7.  Granulocyte colony-stimulating factor delays neutrophil apoptosis by inhibition of calpains upstream of caspase-3.

Authors:  Bram J van Raam; Agata Drewniak; Vincent Groenewold; Timo K van den Berg; Taco W Kuijpers
Journal:  Blood       Date:  2008-06-04       Impact factor: 22.113

Review 8.  The tumor antigen EpCAM: tetraspanins and the tight junction protein claudin-7, new partners, new functions.

Authors:  Francois Le Naour; Margot Zoller
Journal:  Front Biosci       Date:  2008-05-01

Review 9.  Mammalian Rho GTPases: new insights into their functions from in vivo studies.

Authors:  Sarah J Heasman; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2008-09       Impact factor: 94.444

10.  Immunohistochemical categorisation of ductal carcinoma in situ of the breast.

Authors:  P Meijnen; J L Peterse; N Antonini; E J Th Rutgers; M J van de Vijver
Journal:  Br J Cancer       Date:  2007-11-27       Impact factor: 7.640

View more
  24 in total

1.  Structure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by α3β1 versus α6β4 integrin.

Authors:  Shannin Zevian; Nicole E Winterwood; Christopher S Stipp
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

Review 2.  Tetraspanins and tumor progression.

Authors:  Mekel M Richardson; Lisa K Jennings; Xin A Zhang
Journal:  Clin Exp Metastasis       Date:  2010-12-24       Impact factor: 5.150

Review 3.  Integrin α3β1 as a breast cancer target.

Authors:  Sita Subbaram; C Michael Dipersio
Journal:  Expert Opin Ther Targets       Date:  2011-08-13       Impact factor: 6.902

4.  Identification of the tetraspanin CD82 as a new barrier to xenotransplantation.

Authors:  Soad M Saleh; Ranjit S Parhar; Reem S Al-Hejailan; Razan H Bakheet; Hala S Khaleel; Hanif G Khalak; Anason S Halees; Marya Z Zaidi; Brian F Meyer; Gisella P Yung; Jörg D Seebach; Walter Conca; Khalid S Khabar; Kate S Collison; Futwan A Al-Mohanna
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

5.  CD151 represses mammary gland development by maintaining the niches of progenitor cells.

Authors:  Yuanqin Yin; Xinyu Deng; Zeyi Liu; Lauren A Baldwin; Jason Lefringhouse; Jiayang Zhang; John T Hoff; Sonia F Erfani; Edmund B Rucker; Kathleen O'Connor; Chunming Liu; Yadi Wu; Binhua P Zhou; Xiuwei H Yang
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  Expression of CD151/Tspan24 and integrin alpha 3 complex in aid of prognostication of HER2-negative high-grade ductal carcinoma in situ.

Authors:  Hanna M Romanska; Piotr Potemski; Renata Kusinska; Janusz Kopczynski; Rafal Sadej; Radzislaw Kordek
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

7.  The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis.

Authors:  Ruiyan Huang; Junbai Li; Feng Pan; Baofan Zhang; Yufeng Yao
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

8.  CD151: Basis Sequence: Mouse.

Authors:  Trenis D Palmer; Andries Zijlstra
Journal:  AFCS Nat Mol Pages       Date:  2011

9.  Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.

Authors:  Xinyu Deng; Qinglin Li; John Hoff; Marian Novak; Helen Yang; Hongyan Jin; Sonia F Erfani; Chandan Sharma; Pengcheng Zhou; Isaac Rabinovitz; Arnoud Sonnenberg; Yajun Yi; Peter Zhou; Christopher S Stipp; David M Kaetzel; Martin E Hemler; Xiuwei H Yang
Journal:  Neoplasia       Date:  2012-08       Impact factor: 5.715

10.  Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression.

Authors:  Trenis D Palmer; Carlos H Martínez; Catalina Vasquez; Katie E Hebron; Celestial Jones-Paris; Shanna A Arnold; Susanne M Chan; Venu Chalasani; Jose A Gomez-Lemus; Andrew K Williams; Joseph L Chin; Giovanna A Giannico; Tatiana Ketova; John D Lewis; Andries Zijlstra
Journal:  Cancer Res       Date:  2013-11-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.